NASDAQEquity · Weekly research terminal

FRNM

Freenome, Inc. Common stock

US Healthcare Diagnostics & Research

Latest week
14 Aug 2026
Weekly close
11.56 USD
Fair value
11.28 USD
Next-week expectancy
Negative 0.00%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

NASDAQ · Equity · United States

FRNM

Freenome, Inc. Common stock

Healthcare Diagnostics & Research

Freenome Holdings, Inc. is a biotechnology company focused on developing blood-based tests for early cancer detection using artificial intelligence and multiomics technology. The company is headquartered in Brisbane, California.

Last updated
14 Aug 2026
Exchange
NASDAQ · NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Market capitalisation
1,226,503,000
Fair value reference
11.28
Next-week expectancy
Negative · 0.00%

Over the latest 12 completed weeks ending 2026-08-14, FRNM rose 2.85%, moving from 11.24 to 11.56. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is negative at 0.00% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
11.56
12-Week Change
2.85%
Trend Signal
Inactive
Next-Week Expectancy
Negative 0.00%
Signal Weeks
0 of 4

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
11.56
12-Week Change
2.85%
Trend Signal
Inactive
Next-Week Expectancy
Negative 0.00%
Signal Weeks
0 of 4
Vs Fair Value
Above
Market Dynamics
0.00

Over the latest 12 completed weeks ending 2026-08-14, FRNM rose 2.85%, moving from 11.24 to 11.56. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is negative at 0.00% based on similar historical setup states.

Industry Peers

United States equities in Diagnostics & Research

Stock Exchange Week Open High Low Close Change
MDXH MDxHealth SA ADR NASDAQ 14 Aug 2026 0.48 1.13 0.43 0.81 68.33%
ADVB Advanced Biomed Inc. Common Stock NASDAQ 14 Aug 2026 6.23 9.50 6.08 8.95 43.66%
PRE Prenetics Global Ltd NASDAQ 14 Aug 2026 18.10 20.57 17.95 19.75 9.12%
CRL Charles River Laboratories NYSE 14 Aug 2026 265.65 288.02 265.49 280.05 5.42%
RDNT RadNet Inc NASDAQ 14 Aug 2026 73.03 78.86 69.81 76.35 4.55%
TWST Twist Bioscience Corp NASDAQ 14 Aug 2026 113.56 126.40 113.18 118.57 4.41%
QUCY Quantum Cyber N.V. NASDAQ 14 Aug 2026 1.44 1.57 1.23 1.48 2.43%
RVTY Revvity Inc. NYSE 14 Aug 2026 114.22 118.34 112.68 116.84 2.29%
ILMN Illumina Inc NASDAQ 14 Aug 2026 186.69 194.50 186.64 190.89 2.25%
WGS GeneDx Holdings Corp. NASDAQ 14 Aug 2026 76.64 83.87 75.58 78.08 1.88%
WAT Waters Corporation NYSE 14 Aug 2026 405.77 420.26 402.63 412.17 1.58%
A Agilent Technologies Inc NYSE 14 Aug 2026 146.26 150.24 145.45 148.53 1.55%
OPK Opko Health Inc NASDAQ 14 Aug 2026 1.36 1.43 1.32 1.38 1.47%
SHC Sotera Health Co NASDAQ 14 Aug 2026 18.66 19.27 18.61 18.89 1.23%
BLLN BillionToOne, Inc. Class A Common Stock NASDAQ 14 Aug 2026 93.00 99.53 91.90 93.33 0.35%
TMO Thermo Fisher Scientific Inc NYSE 14 Aug 2026 588.53 606.75 587.51 588.29 -0.04%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context